Sector pending / Medical LaboratoriesUpdated 2026-05-10 22:07 UTC

KOSDAQ/086040 stock hub

KOSDAQ/086040 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/086040is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

49.2B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/086040

In the news

Latest news · KOSDAQ/086040

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E42.3

P25 n/aP50 n/aP75 n/a

ROE-4.7

P25 n/aP50 n/aP75 n/a

ROIC-8.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/086040 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

KRW

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	188
Enterprise value	KRW 75.3B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Medical Laboratories
Last refreshed	2026-05-10
Market cap	KRW 49.2B
Price	KRW 3,165
Price currency	KRW
Rev Per Employee	250,088,490.9x
Sic	8071
Symbol	kosdaq/086040
Website	https://www.biotoxtech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.36%
EV Earnings	64.8x
EV/FCF	16.69x
EV/Sales	1.6x
FCF yield	9.18%
P/B ratio	1.54x
P/E ratio	42.3x
P/S ratio	1.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.57%
EBITDA Margin	-3.35%
FCF margin	9.6%
Gross margin	12.34%
Gross Profit	KRW 5.8B
Gross Profit Growth	132.14%
Gross Profit Growth Q	111.23%
Gross Profit Growth3 Y	-22.43%
Gross Profit Growth5 Y	-1.94%
Net Income	KRW 1.2B
Net Income Growth3 Y	-24.72%
Net Income Growth5 Y	-14.95%
Pretax Margin	-0.74%
Profit Margin	2.47%
Profit Per Employee	KRW 6.2M
ROA	-2.76
Roa5y	-1.27
ROCE	-12.81
ROE	-4.74
Roe5y	-7.38
ROIC	-8.47
Roic5y	-4.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.89%
Cagr15y	0.43%
Cagr1y	9.71%
Cagr3y	-28.77%
Cagr5y	-21.48%
EPS Growth3 Y	-26.43
EPS Growth5 Y	-16.19
FCF Growth Q	51.77%
FCF Growth5 Y	7.15%
OCF Growth Q	49.44%
OCF Growth5 Y	7.78%
Revenue Growth	13.73x
Revenue Growth Q	24.75x
Revenue Growth3 Y	8.03x
Revenue Growth5 Y	12.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.35
Assets	KRW 131.6B
Cash	KRW 28.1B
Current Assets	KRW 48.6B
Current Liabilities	KRW 85.5B
Debt	KRW 62.5B
Debt Equity	KRW 1.96
Debt FCF	KRW 13.84
Equity	KRW 31.9B
Interest Coverage	-1.09
Liabilities	KRW 99.7B
Long Term Assets	KRW 83B
Long Term Liabilities	KRW 14.2B
Net Cash	KRW -34.4B
Net Cash By Market Cap	KRW -69.84
Net Debt Equity	KRW 1.08
Net Debt FCF	KRW 7.61
Tangible Book Value	KRW 38.9B
Tangible Book Value Per Share	KRW 2,466
WACC	7.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.57
Inventory Turnover	3.75
Net Working Capital	KRW -13.8B
Quick ratio	0.44
Working Capital	KRW -36.9B
Working Capital Turnover	KRW -1.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-45.52%
1Y total return	9.71%
200-day SMA	2,954.5
3Y total return	-63.87%
50-day SMA	3,243.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-70.14%
All Time High	23,600
All Time High Change	-86.59%
All Time High Date	2018-04-16
All Time Low	780
All Time Low Change	305.77%
All Time Low Date	2008-10-28
ATR	136
Beta	0.55
Beta1y	0.26
Beta2y	0.39
Ch YTD	12.43
High	3,190
High52	4,115
High52 Date	2026-02-24
High52ch	-23.09%
Low	3,095
Low52	2,470
Low52 Date	2026-02-05
Low52ch	28.14%
Ma50ch	-2.41%
Price vs 200-day SMA	7.12%
RSI	43.12
RSI Monthly	40.47
RSI Weekly	51.77
Sharpe ratio	0.21x
Sortino ratio	0.51
Total Return	0.99%
Tr YTD	12.43
Tr15y	6.62%
Tr1m	2.93%
Tr1w	-4.09%
Tr3m	22.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -5.9B
Operating margin	-12.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,355,224%
Net Borrowing	-4,490,928,760
Shares Insiders	15.15%
Shares Out	15,720,789
Shares Qo Q	-12.52%
Shares Yo Y	-0.99%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 4.4B
Average Volume	62,454.55x
Bv Per Share	2,547.2
CAPEX	KRW -2.1B
Ch10y	-45.52
Ch15y	-1.09
Ch1m	2.93
Ch1w	-4.09
Ch1y	9.71
Ch3m	22.44
Ch3y	-63.87
Ch5y	-70.14
Ch6m	20.34
Change	0.64%
Change From Open	0.64
Close	3,145
Days Gap	0
Depreciation Amortization	4,332,592,000
Dollar Volume	92,120,490
Earnings Date	2026-03-27
EBIT	KRW -5.9B
EBITDA	KRW -1.6B
EPS	KRW 74
F Score	6
FCF	KRW 4.5B
FCF EV Yield	5.99x
FCF Per Share	KRW 287
Financing CF	-5,488,936,210
Fiscal Year End	December
Founded	2,000
Graham Number	2059.40429
Graham Upside	-34.93
Income Tax	KRW 1.2B
Investing CF	6,182,904,860
Is Primary Listing	1
Last Earnings Date	2025-08-14
Last Report Date	2025-12-31
Lynch Fair Value	KRW 370
Lynch Upside	-88.31
Ma150	2,930.1
Ma150ch	8.02%
Ma20	3,296.3
Ma20ch	-3.98%
Net CF	7,262,069,310
Open	3,145
P FCF Ratio	10.9
P OCF Ratio	7.41
Position In Range	73.68
Ppne	55,071,417,610
Price Date	2026-05-07
Ptbv Ratio	1.27
Relative Volume	0.46x
Revenue	47,016,636,290x
SBC By Revenue	0.28x
Share Based Comp	133,636,000
Tax By Revenue	2.61x
Tr6m	20.34%
Volume	29,106
Z Score	0.17

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/086040 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/086040 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/086040?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+15.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.0%

Negative means the company is buying back shares.

Technical

KOSDAQ/086040 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

+7.1%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/086040

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/086040 stock rating?

kosdaq/086040 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/086040 analysis?

The full report lives at /stocks/kosdaq/086040/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/086040?

The latest report frames kosdaq/086040 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/086040 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.